We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTX icon
2976
Avalo Therapeutics
AVTX
$1.06B
$297K ﹤0.01%
19
+2
+12% +$21.1K
TWIN icon
2977
Twin Disc
TWIN
$342M
$296K ﹤0.01%
26,836
+2,592
+11% +$27.1K
XXII
2978
22nd Century Group
XXII
$1.5M
0
OYST
2979
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$294K ﹤0.01%
+11,999
New +$211K
EVI icon
2980
EVI Industries
EVI
$181M
$293K ﹤0.01%
10,835
HBB icon
2981
Hamilton Beach Brands
HBB
$444M
$291K ﹤0.01%
15,228
+103
+0.7% +$1.89K
PAMT
2982
PAMT Corp
PAMT
$287M
$289K ﹤0.01%
20,028
MBIO icon
2983
Mustang Bio
MBIO
$4.47M
$288K ﹤0.01%
94
CYCN icon
2984
Cyclerion Therapeutics
CYCN
$16.8M
$287K ﹤0.01%
5,272
-359
-6% -$33.5K
SGA icon
2985
Saga Communications
SGA
$61.4M
$284K ﹤0.01%
9,326
FGBI icon
2986
First Guaranty Bancshares
FGBI
$139M
$283K ﹤0.01%
14,260
-1
-0% -$18
OTRK
2987
DELISTED
Ontrak
OTRK
$283K ﹤0.01%
192
OPBK icon
2988
OP Bancorp
OPBK
$233M
$282K ﹤0.01%
27,171
SHSP
2989
DELISTED
SharpSpring, Inc.
SHSP
$282K ﹤0.01%
24,556
VHI icon
2990
Valhi
VHI
$474M
$281K ﹤0.01%
12,490
-1,282
-9% -$29.4K
AVXL icon
2991
Anavex Life Sciences
AVXL
$314M
$276K ﹤0.01%
106,221
FCEL icon
2992
FuelCell Energy
FCEL
$1.59B
$275K ﹤0.01%
+3,649
New +$63.5K
GNE icon
2993
Genie Energy
GNE
$381M
$275K ﹤0.01%
35,558
MRNS
2994
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$274K ﹤0.01%
31,690
EVLO
2995
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$273K ﹤0.01%
3,361
-442
-12% -$49.5K
RVLP
2996
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$269K ﹤0.01%
38,374
-2,788
-7% -$14.9K
IRMD icon
2997
iRadimed
IRMD
$1.15B
$267K ﹤0.01%
11,385
+885
+8% +$20.7K
GENC icon
2998
Gencor Industries
GENC
$235M
$266K ﹤0.01%
22,734
GALT icon
2999
Galectin Therapeutics
GALT
$315M
$265K ﹤0.01%
92,444
SAMG icon
3000
Silvercrest Asset Management
SAMG
$77.6M
$264K ﹤0.01%
20,947

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.